Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2.

Saved in:
Bibliographic Details
Title: Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2.
Authors: Casás-Selves M; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Drug Discovery Program, Ontario Institute for Cancer Research, 661 University Avenue, Suite 510, Toronto, ON, M5G 0A3, Canada., Zhang AX; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., Dowling JE; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., Hallén S; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Discovery Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden., Kawatkar A; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., Pace NJ; Department of Chemistry, Boston College, Chestnut Hill, MA, 02467, USA., Denz CR; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., Pontz T; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., Garahdaghi F; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Synageva BioPharma Corp., 33 Hayden Avenue, Lexington, MA, 02421, USA., Cao Q; Discovery Sciences-Computational Chemistry, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Ra Pharmaceuticals, Inc., 87 Cambridge Park Drive, Cambridge, MA, 02140, USA., Sabirsh A; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Discovery Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden., Thakur K; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., O'Connell N; Discovery Sciences-Structure and Biophysics, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Nurix, Inc., 1700 Owens Street, Suite 290, San Francisco, CA, 94158, USA., Hu J; Discovery Sciences-Structure and Biophysics, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Shire, 300 Shire Way, Lexington, MA, 02421, USA., Cornella-Taracido I; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Discovery Chemistry, Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115, USA., Weerapana E; Department of Chemistry, Boston College, Chestnut Hill, MA, 02467, USA., Zinda M; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA., Goodnow RA Jr; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Pharmaron, 303 Wyman Street, Room 322, Waltham, MA, 02451, USA., Castaldi MP; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.
Source: ChemMedChem [ChemMedChem] 2017 Jun 21; Vol. 12 (12), pp. 917-924. Date of Electronic Publication: 2017 Apr 26.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28371485
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Casás-Selves+M%22">Casás-Selves M</searchLink>; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Drug Discovery Program, Ontario Institute for Cancer Research, 661 University Avenue, Suite 510, Toronto, ON, M5G 0A3, Canada.<br /><searchLink fieldCode="AU" term="%22Zhang+AX%22">Zhang AX</searchLink>; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Dowling+JE%22">Dowling JE</searchLink>; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Hallén+S%22">Hallén S</searchLink>; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Discovery Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden.<br /><searchLink fieldCode="AU" term="%22Kawatkar+A%22">Kawatkar A</searchLink>; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Pace+NJ%22">Pace NJ</searchLink>; Department of Chemistry, Boston College, Chestnut Hill, MA, 02467, USA.<br /><searchLink fieldCode="AU" term="%22Denz+CR%22">Denz CR</searchLink>; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Pontz+T%22">Pontz T</searchLink>; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Garahdaghi+F%22">Garahdaghi F</searchLink>; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Synageva BioPharma Corp., 33 Hayden Avenue, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Cao+Q%22">Cao Q</searchLink>; Discovery Sciences-Computational Chemistry, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Ra Pharmaceuticals, Inc., 87 Cambridge Park Drive, Cambridge, MA, 02140, USA.<br /><searchLink fieldCode="AU" term="%22Sabirsh+A%22">Sabirsh A</searchLink>; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Discovery Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden.<br /><searchLink fieldCode="AU" term="%22Thakur+K%22">Thakur K</searchLink>; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22O'Connell+N%22">O'Connell N</searchLink>; Discovery Sciences-Structure and Biophysics, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Nurix, Inc., 1700 Owens Street, Suite 290, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Hu+J%22">Hu J</searchLink>; Discovery Sciences-Structure and Biophysics, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Shire, 300 Shire Way, Lexington, MA, 02421, USA.<br /><searchLink fieldCode="AU" term="%22Cornella-Taracido+I%22">Cornella-Taracido I</searchLink>; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Discovery Chemistry, Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston, MA, 02115, USA.<br /><searchLink fieldCode="AU" term="%22Weerapana+E%22">Weerapana E</searchLink>; Department of Chemistry, Boston College, Chestnut Hill, MA, 02467, USA.<br /><searchLink fieldCode="AU" term="%22Zinda+M%22">Zinda M</searchLink>; Oncology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Goodnow+RA+Jr%22">Goodnow RA Jr</searchLink>; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.; Present address: Pharmaron, 303 Wyman Street, Room 322, Waltham, MA, 02451, USA.<br /><searchLink fieldCode="AU" term="%22Castaldi+MP%22">Castaldi MP</searchLink>; Discovery Sciences-Chemical Biology, Innovative Medicines and Early Discovery Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, MA, 02451, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101259013%22">ChemMedChem</searchLink> [ChemMedChem] 2017 Jun 21; Vol. 12 (12), pp. 917-924. <i>Date of Electronic Publication: </i>2017 Apr 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-VCH%22">Wiley-VCH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101259013 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1860-7187 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218607179%22">18607179 </searchLink><i>NLM ISO Abbreviation: </i>ChemMedChem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28371485
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cmdc.201700028
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 917
    Titles:
      – TitleFull: Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Casás-Selves M
      – PersonEntity:
          Name:
            NameFull: Zhang AX
      – PersonEntity:
          Name:
            NameFull: Dowling JE
      – PersonEntity:
          Name:
            NameFull: Hallén S
      – PersonEntity:
          Name:
            NameFull: Kawatkar A
      – PersonEntity:
          Name:
            NameFull: Pace NJ
      – PersonEntity:
          Name:
            NameFull: Denz CR
      – PersonEntity:
          Name:
            NameFull: Pontz T
      – PersonEntity:
          Name:
            NameFull: Garahdaghi F
      – PersonEntity:
          Name:
            NameFull: Cao Q
      – PersonEntity:
          Name:
            NameFull: Sabirsh A
      – PersonEntity:
          Name:
            NameFull: Thakur K
      – PersonEntity:
          Name:
            NameFull: O'Connell N
      – PersonEntity:
          Name:
            NameFull: Hu J
      – PersonEntity:
          Name:
            NameFull: Cornella-Taracido I
      – PersonEntity:
          Name:
            NameFull: Weerapana E
      – PersonEntity:
          Name:
            NameFull: Zinda M
      – PersonEntity:
          Name:
            NameFull: Goodnow RA Jr
      – PersonEntity:
          Name:
            NameFull: Castaldi MP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 06
              Text: 2017 Jun 21
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1860-7187
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: ChemMedChem
              Type: main
ResultId 1